ForMED Ventures

Aqua Medical, Inc. is focused on developing innovative, vapor-based, endoscopic ablation technology aimed at treating gastrointestinal diseases and preventing gastrointestinal cancers. Founded in 2016 and based in Santa Ana, California, the company utilizes high-temperature water vapor generated by a radiofrequency generator. This vapor is delivered endoscopically through proprietary catheters, allowing for a minimally invasive approach to treat various conditions within the gastrointestinal tract, including pancreatic cysts and esophageal issues. Aqua Medical's platform technology offers a convenient and effective alternative to traditional surgical methods, enhancing treatment options for medical practitioners and their patients.

Eximis Surgical, founded in 2014 and headquartered in Louisville, Colorado, specializes in developing innovative technology for laparoscopic surgery. The company has created a specimen removal device that enables surgeons to efficiently extract large specimens through small incisions. This device utilizes radio frequency (RF) energized cutting wires, which are temporarily held in a containment bag, allowing for quick and safe specimen removal. By integrating seamlessly into existing physician protocols, Eximis Surgical's technology significantly reduces the time required for specimen extraction, minimizes patient discomfort, and ensures safe surgical outcomes. Additionally, the device separates specimens into narrow strips, facilitating the creation of clean tissue segments for accurate pathology identification, thereby enhancing the overall effectiveness of minimally invasive surgery.

Advanced NanoTherapies, Inc. is a company that specializes in developing medical devices utilizing Sirolimus for the treatment of atherosclerosis and blockages associated with coronary and peripheral artery diseases. Founded in 2018, the company is based in Cleveland, Ohio, and focuses on a unique nanoparticle technology platform aimed at improving drug delivery for cardiovascular and endovascular applications. This innovative technology enhances medication uptake and retention within cells, providing clinicians with safer treatment options for patients suffering from peripheral artery disease. Through its advancements, Advanced NanoTherapies aims to address significant health challenges in the cardiovascular field.